How PureTech’s lung fi­bro­sis drug stacks up against the com­pe­ti­tion

PureTech Health’s tweaked form of Roche’s lung fi­bro­sis drug Es­bri­et slowed lung func­tion de­cline by a greater de­gree than Es­bri­et it­self, with com­pa­ra­ble safe­ty, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER